Amyotrophic Lateral Sclerosis (ALS) Market Report

Global Amyotrophic Lateral Sclerosis (ALS) Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • POSTDATE：Jun 03, 2021
  • PAGES：231
  • REPORT CODE：GMM693861
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Amyotrophic Lateral Sclerosis (ALS) Market is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of XX.0% during the forecast period. The research provides insights for the global Amyotrophic Lateral Sclerosis (ALS) market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Amyotrophic Lateral Sclerosis (ALS) industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Global Amyotrophic Lateral Sclerosis (ALS) Market Segmentations:

    By Players:

    • Glemark Generics

    • Lunan Pharma

    • Mylan Pharma

    • Mitsubishi Tanabe Pharma

    • Covis Pharma

    • Apotex

    • Sanofi

    • Sun Pharma

    By Types:

    • Riluzole

    • Edaravone (Radicava)

    • Other

    By End-User:

    • Hospital

    • Drugs Store

    • Other

    By Regions:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Amyotrophic Lateral Sclerosis (ALS) Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global Amyotrophic Lateral Sclerosis (ALS) Market Size and Growth Rate of Riluzole from 2014 to 2026

      • 1.3.2 Global Amyotrophic Lateral Sclerosis (ALS) Market Size and Growth Rate of Edaravone (Radicava) from 2014 to 2026

      • 1.3.3 Global Amyotrophic Lateral Sclerosis (ALS) Market Size and Growth Rate of Other from 2014 to 2026

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global Amyotrophic Lateral Sclerosis (ALS) Market Size and Growth Rate of Hospital from 2014 to 2026

      • 1.4.2 Global Amyotrophic Lateral Sclerosis (ALS) Market Size and Growth Rate of Drugs Store from 2014 to 2026

      • 1.4.3 Global Amyotrophic Lateral Sclerosis (ALS) Market Size and Growth Rate of Other from 2014 to 2026

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America Amyotrophic Lateral Sclerosis (ALS) Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.1 United States Amyotrophic Lateral Sclerosis (ALS) Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.2 Canada Amyotrophic Lateral Sclerosis (ALS) Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.3 Mexico Amyotrophic Lateral Sclerosis (ALS) Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Amyotrophic Lateral Sclerosis (ALS) Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.1 Germany Amyotrophic Lateral Sclerosis (ALS) Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.2 UK Amyotrophic Lateral Sclerosis (ALS) Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.3 France Amyotrophic Lateral Sclerosis (ALS) Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.4 Italy Amyotrophic Lateral Sclerosis (ALS) Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.5 Nordic Countries Amyotrophic Lateral Sclerosis (ALS) Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.6 Spain Amyotrophic Lateral Sclerosis (ALS) Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.7 Belgium Amyotrophic Lateral Sclerosis (ALS) Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.8 Poland Amyotrophic Lateral Sclerosis (ALS) Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.9 Russia Amyotrophic Lateral Sclerosis (ALS) Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.10 Turkey Amyotrophic Lateral Sclerosis (ALS) Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.1 China Amyotrophic Lateral Sclerosis (ALS) Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.2 Japan Amyotrophic Lateral Sclerosis (ALS) Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.3 Australia and New Zealand Amyotrophic Lateral Sclerosis (ALS) Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.4 India Amyotrophic Lateral Sclerosis (ALS) Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.5 ASEAN Countries Amyotrophic Lateral Sclerosis (ALS) Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.6 South Korea Amyotrophic Lateral Sclerosis (ALS) Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Latin America, Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.1 GCC Countries Amyotrophic Lateral Sclerosis (ALS) Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.2 Brazil Amyotrophic Lateral Sclerosis (ALS) Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.3 Nigeria Amyotrophic Lateral Sclerosis (ALS) Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.4 South Africa Amyotrophic Lateral Sclerosis (ALS) Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.5 Argentina Amyotrophic Lateral Sclerosis (ALS) Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Amyotrophic Lateral Sclerosis (ALS) Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Amyotrophic Lateral Sclerosis (ALS) by Major Types

      • 3.4.1 Amyotrophic Lateral Sclerosis (ALS) Market Size and Growth Rate of Riluzole

      • 3.4.2 Amyotrophic Lateral Sclerosis (ALS) Market Size and Growth Rate of Edaravone (Radicava)

      • 3.4.3 Amyotrophic Lateral Sclerosis (ALS) Market Size and Growth Rate of Other

    4 Segmentation of Amyotrophic Lateral Sclerosis (ALS) Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Amyotrophic Lateral Sclerosis (ALS) by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Amyotrophic Lateral Sclerosis (ALS) in Hospital

      • 4.4.2 Market Size and Growth Rate of Amyotrophic Lateral Sclerosis (ALS) in Drugs Store

      • 4.4.3 Market Size and Growth Rate of Amyotrophic Lateral Sclerosis (ALS) in Other

    5 Market Analysis by Major Regions

    • 5.1 Global Amyotrophic Lateral Sclerosis (ALS) Production Analysis by Major Regions

    • 5.2 Global Amyotrophic Lateral Sclerosis (ALS) Consumption Analysis by Major Regions

    • 5.3 Global Amyotrophic Lateral Sclerosis (ALS) Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Amyotrophic Lateral Sclerosis (ALS) Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe Amyotrophic Lateral Sclerosis (ALS) Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Production, Import, Consumption and Export Analysis

    6 Product Commodity of Amyotrophic Lateral Sclerosis (ALS) Market in Major Countries

    • 6.1 Top 5 Export Countries in Amyotrophic Lateral Sclerosis (ALS) market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in Amyotrophic Lateral Sclerosis (ALS) market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Amyotrophic Lateral Sclerosis (ALS) market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Amyotrophic Lateral Sclerosis (ALS) market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in Amyotrophic Lateral Sclerosis (ALS) market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Amyotrophic Lateral Sclerosis (ALS) market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7 North America Amyotrophic Lateral Sclerosis (ALS) Landscape Analysis

    • 7.1 North America Amyotrophic Lateral Sclerosis (ALS) Landscape Analysis by Major Types

    • 7.2 North America Amyotrophic Lateral Sclerosis (ALS) Landscape Analysis by Major End-Users

    • 7.3 North America Amyotrophic Lateral Sclerosis (ALS) Landscape Analysis by Major Countries

      • 7.3.1 United States Amyotrophic Lateral Sclerosis (ALS) Market Volume and Growth Rate

      • 7.3.2 Canada Amyotrophic Lateral Sclerosis (ALS) Market Volume and Growth Rate

      • 7.3.3 Mexico Amyotrophic Lateral Sclerosis (ALS) Market Volume and Growth Rate

    8 Europe Amyotrophic Lateral Sclerosis (ALS) Landscape Analysis

    • 8.1 Europe Amyotrophic Lateral Sclerosis (ALS) Landscape Analysis by Major Types

    • 8.2 Europe Amyotrophic Lateral Sclerosis (ALS) Landscape Analysis by Major End-Users

    • 8.3 Europe Amyotrophic Lateral Sclerosis (ALS) Landscape Analysis by Major Countries

      • 8.3.1 Germany Amyotrophic Lateral Sclerosis (ALS) Market Volume and Growth Rate

      • 8.3.2 UK Amyotrophic Lateral Sclerosis (ALS) Market Volume and Growth Rate

      • 8.3.3 France Amyotrophic Lateral Sclerosis (ALS) Market Volume and Growth Rate

      • 8.3.4 Italy Amyotrophic Lateral Sclerosis (ALS) Market Volume and Growth Rate

      • 8.3.5 Nordic Countries Amyotrophic Lateral Sclerosis (ALS) Market Volume and Growth Rate

      • 8.3.6 Spain Amyotrophic Lateral Sclerosis (ALS) Market Volume and Growth Rate

      • 8.3.7 Belgium Amyotrophic Lateral Sclerosis (ALS) Market Volume and Growth Rate

      • 8.3.8 Poland Amyotrophic Lateral Sclerosis (ALS) Market Volume and Growth Rate

      • 8.3.9 Russia Amyotrophic Lateral Sclerosis (ALS) Market Volume and Growth Rate

      • 8.3.10 Turkey Amyotrophic Lateral Sclerosis (ALS) Market Volume and Growth Rate

    9 Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Landscape Analysis

    • 9.1 Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Landscape Analysis by Major Types

    • 9.2 Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Landscape Analysis by Major Countries

      • 9.3.1 China Amyotrophic Lateral Sclerosis (ALS) Market Volume and Growth Rate

      • 9.3.2 Japan Amyotrophic Lateral Sclerosis (ALS) Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand Amyotrophic Lateral Sclerosis (ALS) Market Volume and Growth Rate

      • 9.3.4 India Amyotrophic Lateral Sclerosis (ALS) Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries Amyotrophic Lateral Sclerosis (ALS) Market Volume and Growth Rate

      • 9.3.6 South Korea Amyotrophic Lateral Sclerosis (ALS) Market Volume and Growth Rate

    10 Latin America, Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Landscape Analysis

    • 10.1 Latin America, Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries Amyotrophic Lateral Sclerosis (ALS) Market Volume and Growth Rate

      • 10.3.2 Brazil Amyotrophic Lateral Sclerosis (ALS) Market Volume and Growth Rate

      • 10.3.3 Nigeria Amyotrophic Lateral Sclerosis (ALS) Market Volume and Growth Rate

      • 10.3.4 South Africa Amyotrophic Lateral Sclerosis (ALS) Market Volume and Growth Rate 

      • 10.3.5 Argentina Amyotrophic Lateral Sclerosis (ALS) Market Volume and Growth Rate

    11 Major Players Profile

    • 11.1 Glemark Generics

      • 11.1.1 Glemark Generics Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Lunan Pharma

      • 11.2.1 Lunan Pharma Company Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Mylan Pharma

      • 11.3.1 Mylan Pharma Company Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Mitsubishi Tanabe Pharma

      • 11.4.1 Mitsubishi Tanabe Pharma Company Profile and Recent Development

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Covis Pharma

      • 11.5.1 Covis Pharma Company Profile and Recent Development

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Apotex

      • 11.6.1 Apotex Company Profile and Recent Development

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Sanofi

      • 11.7.1 Sanofi Company Profile and Recent Development

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 Sun Pharma

      • 11.8.1 Sun Pharma Company Profile and Recent Development

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    12 Data Source and Research Methodology

    The List of Tables and Figures (Totals 92 Figures and 131 Tables)

    • Figure Product Picture

    • Figure Amyotrophic Lateral Sclerosis (ALS) Market Size and Growth Rate of Riluzole from 2014 to 2026

    • Figure Amyotrophic Lateral Sclerosis (ALS) Market Size and Growth Rate of Edaravone (Radicava) from 2014 to 2026

    • Figure Amyotrophic Lateral Sclerosis (ALS) Market Size and Growth Rate of Other from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Global Amyotrophic Lateral Sclerosis (ALS) Market Size and Growth Rate of Hospital from 2014 to 2026

    • Figure Global Amyotrophic Lateral Sclerosis (ALS) Market Size and Growth Rate of Drugs Store from 2014 to 2026

    • Figure Global Amyotrophic Lateral Sclerosis (ALS) Market Size and Growth Rate of Other from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure North America Amyotrophic Lateral Sclerosis (ALS) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure United States Amyotrophic Lateral Sclerosis (ALS) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Amyotrophic Lateral Sclerosis (ALS) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Amyotrophic Lateral Sclerosis (ALS) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Amyotrophic Lateral Sclerosis (ALS) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Amyotrophic Lateral Sclerosis (ALS) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure UK Amyotrophic Lateral Sclerosis (ALS) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure France Amyotrophic Lateral Sclerosis (ALS) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Amyotrophic Lateral Sclerosis (ALS) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Amyotrophic Lateral Sclerosis (ALS) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Amyotrophic Lateral Sclerosis (ALS) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Amyotrophic Lateral Sclerosis (ALS) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Amyotrophic Lateral Sclerosis (ALS) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Amyotrophic Lateral Sclerosis (ALS) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Amyotrophic Lateral Sclerosis (ALS) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure China Amyotrophic Lateral Sclerosis (ALS) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Amyotrophic Lateral Sclerosis (ALS) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Australia and New Zealand Amyotrophic Lateral Sclerosis (ALS) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure India Amyotrophic Lateral Sclerosis (ALS) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Amyotrophic Lateral Sclerosis (ALS) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Amyotrophic Lateral Sclerosis (ALS) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Latin America, Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Countries Amyotrophic Lateral Sclerosis (ALS) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Amyotrophic Lateral Sclerosis (ALS) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nigeria Amyotrophic Lateral Sclerosis (ALS) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Amyotrophic Lateral Sclerosis (ALS) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Amyotrophic Lateral Sclerosis (ALS) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Amyotrophic Lateral Sclerosis (ALS) Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Amyotrophic Lateral Sclerosis (ALS)

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Amyotrophic Lateral Sclerosis (ALS) by Different Types from 2014 to 2026

    • Table Consumption Share of Amyotrophic Lateral Sclerosis (ALS) by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Riluzole

    • Figure Market Size and Growth Rate of Edaravone (Radicava)

    • Figure Market Size and Growth Rate of Other

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Amyotrophic Lateral Sclerosis (ALS) by Different End-Users from 2014 to 2026

    • Table Consumption Share of Amyotrophic Lateral Sclerosis (ALS) by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Hospital

    • Figure Market Size and Growth Rate of Drugs Store

    • Figure Market Size and Growth Rate of Other

    • Table Global Amyotrophic Lateral Sclerosis (ALS) Production by Major Regions

    • Table Global Amyotrophic Lateral Sclerosis (ALS) Production Share by Major Regions

    • Figure Global Amyotrophic Lateral Sclerosis (ALS) Production Share by Major Regions in 2014

    • Figure Global Amyotrophic Lateral Sclerosis (ALS) Production Share by Major Regions in 2018

    • Figure Global Amyotrophic Lateral Sclerosis (ALS) Production Share by Major Regions in 2026

    • Table Global Amyotrophic Lateral Sclerosis (ALS) Consumption by Major Regions

    • Table Global Amyotrophic Lateral Sclerosis (ALS) Consumption Share by Major Regions

    • Figure Global Amyotrophic Lateral Sclerosis (ALS) Consumption Share by Major Regions in 2014

    • Figure Global Amyotrophic Lateral Sclerosis (ALS) Consumption Share by Major Regions in 2018

    • Figure Global Amyotrophic Lateral Sclerosis (ALS) Consumption Share by Major Regions in 2026

    • Table North America Amyotrophic Lateral Sclerosis (ALS) Production, Import, Consumption and Export Analysis

    • Table Europe Amyotrophic Lateral Sclerosis (ALS) Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Amyotrophic Lateral Sclerosis (ALS) market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Amyotrophic Lateral Sclerosis (ALS) market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Amyotrophic Lateral Sclerosis (ALS) market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Amyotrophic Lateral Sclerosis (ALS) market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Amyotrophic Lateral Sclerosis (ALS) Consumption by Types from 2014 to 2026

    • Table North America Amyotrophic Lateral Sclerosis (ALS) Consumption Share by Types from 2014 to 2026

    • Figure North America Amyotrophic Lateral Sclerosis (ALS) Consumption Share by Types in 2014

    • Figure North America Amyotrophic Lateral Sclerosis (ALS) Consumption Share by Types in 2018

    • Figure North America Amyotrophic Lateral Sclerosis (ALS) Consumption Share by Types in 2026

    • Table North America Amyotrophic Lateral Sclerosis (ALS) Consumption by End-Users from 2014 to 2026

    • Table North America Amyotrophic Lateral Sclerosis (ALS) Consumption Share by End-Users from 2014 to 2026

    • Figure North America Amyotrophic Lateral Sclerosis (ALS) Consumption Share by End-Users in 2014

    • Figure North America Amyotrophic Lateral Sclerosis (ALS) Consumption Share by End-Users in 2018

    • Figure North America Amyotrophic Lateral Sclerosis (ALS) Consumption Share by End-Users in 2026

    • Table North America Amyotrophic Lateral Sclerosis (ALS) Consumption by Major Countries from 2014 to 2026

    • Table North America Amyotrophic Lateral Sclerosis (ALS) Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Amyotrophic Lateral Sclerosis (ALS) Consumption Share by Major Countries in 2014

    • Figure North America Amyotrophic Lateral Sclerosis (ALS) Consumption Share by Major Countries in 2018

    • Figure North America Amyotrophic Lateral Sclerosis (ALS) Consumption Share by Major Countries in 2026

    • Figure United States Amyotrophic Lateral Sclerosis (ALS) Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Amyotrophic Lateral Sclerosis (ALS) Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Amyotrophic Lateral Sclerosis (ALS) Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Amyotrophic Lateral Sclerosis (ALS) Consumption by Types from 2014 to 2026

    • Table Europe Amyotrophic Lateral Sclerosis (ALS) Consumption Share by Types from 2014 to 2026

    • Figure Europe Amyotrophic Lateral Sclerosis (ALS) Consumption Share by Types in 2014

    • Figure Europe Amyotrophic Lateral Sclerosis (ALS) Consumption Share by Types in 2018

    • Figure Europe Amyotrophic Lateral Sclerosis (ALS) Consumption Share by Types in 2026

    • Table Europe Amyotrophic Lateral Sclerosis (ALS) Consumption by End-Users from 2014 to 2026

    • Table Europe Amyotrophic Lateral Sclerosis (ALS) Consumption Share by End-Users from 2014 to 2026

    • Figure Europe Amyotrophic Lateral Sclerosis (ALS) Consumption Share by End-Users in 2014

    • Figure Europe Amyotrophic Lateral Sclerosis (ALS) Consumption Share by End-Users in 2018

    • Figure Europe Amyotrophic Lateral Sclerosis (ALS) Consumption Share by End-Users in 2026

    • Table Europe Amyotrophic Lateral Sclerosis (ALS) Consumption by Major Countries from 2014 to 2026

    • Table Europe Amyotrophic Lateral Sclerosis (ALS) Consumption Share by Major Countries from 2014 to 2026

    • Figure Europe Amyotrophic Lateral Sclerosis (ALS) Consumption Share by Major Countries in 2014

    • Figure Europe Amyotrophic Lateral Sclerosis (ALS) Consumption Share by Major Countries in 2018

    • Figure Europe Amyotrophic Lateral Sclerosis (ALS) Consumption Share by Major Countries in 2026

    • Figure Germany Amyotrophic Lateral Sclerosis (ALS) Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Amyotrophic Lateral Sclerosis (ALS) Market Volume and Growth Rate from 2014 to 2026

    • Figure France Amyotrophic Lateral Sclerosis (ALS) Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Amyotrophic Lateral Sclerosis (ALS) Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Amyotrophic Lateral Sclerosis (ALS) Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Amyotrophic Lateral Sclerosis (ALS) Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Amyotrophic Lateral Sclerosis (ALS) Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Amyotrophic Lateral Sclerosis (ALS) Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Amyotrophic Lateral Sclerosis (ALS) Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Consumption by Types from 2014 to 2026

    • Table Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Consumption Share by Types from 2014 to 2026

    • Figure Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Consumption Share by Types in 2014

    • Figure Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Consumption Share by Types in 2018

    • Figure Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Consumption Share by Types in 2026

    • Table Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Consumption by End-Users from 2014 to 2026

    • Table Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Consumption Share by End-Users from 2014 to 2026

    • Figure Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Consumption Share by End-Users in 2014

    • Figure Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Consumption Share by End-Users in 2018

    • Figure Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Consumption Share by End-Users in 2026

    • Table Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Consumption Share by Major Countries from 2014 to 2026

    • Figure Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Consumption Share by Major Countries in 2014

    • Figure Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Consumption Share by Major Countries in 2018

    • Figure Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Consumption Share by Major Countries in 2026

    • Figure China Amyotrophic Lateral Sclerosis (ALS) Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Amyotrophic Lateral Sclerosis (ALS) Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia and New ZealandAmyotrophic Lateral Sclerosis (ALS) Market Volume and Growth Rate from 2014 to 2026

    • Figure India Amyotrophic Lateral Sclerosis (ALS) Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Amyotrophic Lateral Sclerosis (ALS) Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Amyotrophic Lateral Sclerosis (ALS) Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Consumption by Types from 2014 to 2026

    • Table Latin America, Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Consumption Share by Types from 2014 to 2026

    • Figure Latin America, Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Consumption Share by Types in 2014

    • Figure Latin America, Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Consumption Share by Types in 2026

    • Table Latin America, Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Consumption by End-Users from 2014 to 2026

    • Table Latin America, Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Consumption Share by End-Users from 2014 to 2026

    • Figure Latin America, Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Consumption Share by End-Users in 2014

    • Figure Latin America, Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Consumption Share by End-Users in 2026

    • Table Latin America, Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Consumption Share by Major Countries from 2014 to 2026

    • Figure Latin America, Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Consumption Share by Major Countries in 2014

    • Figure Latin America, Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Consumption Share by Major Countries in 2026

    • Figure GCC Countries Amyotrophic Lateral Sclerosis (ALS) Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Amyotrophic Lateral Sclerosis (ALS) Market Volume and Growth Rate from 2014 to 2026

    • Figure Nigeria Amyotrophic Lateral Sclerosis (ALS) Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Amyotrophic Lateral Sclerosis (ALS) Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Amyotrophic Lateral Sclerosis (ALS) Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Glemark Generics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Glemark Generics

    • Figure Sales and Growth Rate Analysis of Glemark Generics

    • Figure Revenue and Market Share Analysis of Glemark Generics

    • Table Product and Service Introduction of Glemark Generics

    • Table Company Profile and Development Status of Lunan Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lunan Pharma

    • Figure Sales and Growth Rate Analysis of Lunan Pharma

    • Figure Revenue and Market Share Analysis of Lunan Pharma

    • Table Product and Service Introduction of Lunan Pharma

    • Table Company Profile and Development Status of Mylan Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan Pharma

    • Figure Sales and Growth Rate Analysis of Mylan Pharma

    • Figure Revenue and Market Share Analysis of Mylan Pharma

    • Table Product and Service Introduction of Mylan Pharma

    • Table Company Profile and Development Status of Mitsubishi Tanabe Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mitsubishi Tanabe Pharma

    • Figure Sales and Growth Rate Analysis of Mitsubishi Tanabe Pharma

    • Figure Revenue and Market Share Analysis of Mitsubishi Tanabe Pharma

    • Table Product and Service Introduction of Mitsubishi Tanabe Pharma

    • Table Company Profile and Development Status of Covis Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Covis Pharma

    • Figure Sales and Growth Rate Analysis of Covis Pharma

    • Figure Revenue and Market Share Analysis of Covis Pharma

    • Table Product and Service Introduction of Covis Pharma

    • Table Company Profile and Development Status of Apotex

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Apotex

    • Figure Sales and Growth Rate Analysis of Apotex

    • Figure Revenue and Market Share Analysis of Apotex

    • Table Product and Service Introduction of Apotex

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

    • Table Company Profile and Development Status of Sun Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sun Pharma

    • Figure Sales and Growth Rate Analysis of Sun Pharma

    • Figure Revenue and Market Share Analysis of Sun Pharma

    • Table Product and Service Introduction of Sun Pharma


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US